Etrumadenant
Showing 1 - 13 of 13
Healthy Participants Trial in Groningen ([14C]-etrumadenant)
Completed
- Healthy Participants
-
Groningen, NZ, NetherlandsPRA Health Sciences (PRA) - Early Development Services (EDS)
Dec 6, 2022
Healthy Participants Trial in Lincoln (Etrumadenant)
Completed
- Healthy Participants
- Etrumadenant
-
Lincoln, NebraskaInvestigational Site
Aug 29, 2022
Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)
Not yet recruiting
- Urothelial Carcinoma
- Metastatic Cancer
- Pemetrexed
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Nov 28, 2022
Non Small Cell Lung Cancer, Non-small Cell Carcinoma, NSCLC Trial in Saint Louis (Zimberelimab, Domvanalimab, Etrumadenant)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Zimberelimab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 8, 2022
Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)
Recruiting
- Dedifferentiated Liposarcoma
- +6 more
- Etrumadenant
- Zimberelimab
-
Basking Ridge, New Jersey
- +6 more
May 23, 2023
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer Trial (Zimberelimab (ZIM), Domvanalimab (DOM), Sacituzumab
Not yet recruiting
- Lung Cancer
- Advanced or Metastatic Non-Small-Cell Lung Cancer
- Zimberelimab (ZIM)
- +9 more
- (no location specified)
Nov 21, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022
Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
-
San Francisco, California
- +1 more
Oct 8, 2022
Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville
Not yet recruiting
- Head and Neck Cancer
- +9 more
- Zimberelimab
- +3 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Aug 9, 2022
Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)
Recruiting
- Rectal Cancer
- Etrumadenant (AB928)
- +3 more
-
New York, New York
- +2 more
Apr 10, 2022
Metastatic Colorectal Cancer Trial in Worldwide (etrumadenant, zimberelimab, mFOLFOX-6 regimen)
Recruiting
- Metastatic Colorectal Cancer
- etrumadenant
- +5 more
-
Birmingham, Alabama
- +62 more
Apr 1, 2022